Sanofi
CEACAM5 ANTIBODY-DRUG CONJUGATE FORMULATION
Last updated:
Abstract:
Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same.
Status:
Application
Type:
Utility
Filling date:
9 Nov 2021
Issue date:
30 Jun 2022